You are here

InterMune

2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters

BNET Pharma

Tue, 02/9/10 - 11:14 am

Cadence Pharmaceuticals

Acorda Therapeutics

Gilead Sciences

Cell Therapeutics

Arena Pharmaceuticals

InterMune gets March FDA review for lung drug

Yahoo/AP

Mon, 02/1/10 - 11:14 am

InterMune to net $93M from stock sale

Bizjournals.com

Fri, 01/22/10 - 10:08 am

InterMune gets FDA priority review for pirfenidone

Marketwatch

Mon, 01/4/10 - 08:50 am

Five Biotech Events to Watch in 2010

TheStreet.com

Wed, 12/16/09 - 11:22 am

Vertex Pharmaceuticals

Alkermes jumps; Cerus, InterMune slide

Marketwatch

Tue, 11/17/09 - 11:20 am

InterMune Hep C Drug Hit With Liver Tox Worry

TheStreet.com

Tue, 11/17/09 - 11:07 am

Biotech Calendar: Key Dates for November

TheStreet.com

Mon, 11/2/09 - 08:52 am

Vertex Pharmaceuticals

Schering Plough

Cadence Pharmaceuticals

Are pharma execs in legal jeopardy?

Fierce Pharma

Wed, 09/30/09 - 10:31 am

InterMune shares fall on 1st-quarter loss; analysts look ahead to developing treatments

Yahoo/AP

Sun, 05/3/09 - 09:25 am

Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly

Seeking Alpha

Thu, 04/2/09 - 08:24 am

Acorda Therapeutics

CV Therapeutics

Arena Pharmaceuticals

Gilead Sciences

MAP Pharmaceuticals

La Jolla Pharmaceutical

Osiris Therapeutics

InterMune Posts Net Loss, Missing Estimates

The Street

Sat, 02/28/09 - 11:10 am

InterMune Batting .500

Motley Fool

Tue, 02/3/09 - 03:30 pm

InterMune Investors Eager for Lung-Drug Data

TheStreet.com

Mon, 01/26/09 - 11:38 am

InterMune's New Hep C Drug Falls Short

TheStreet.com

Mon, 01/12/09 - 10:28 am

Pages